Additional information
White Powder
331943-04-5
ACI-030902
188-190°C
C17H14F3N3O2S
381.37
Ambient
2-8°C
Anti-inflammatory
Pharmaceutical Impurity Standards
4-[3-(4-Methylphenyl)-5- (trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide
4-[3-(4-Methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide
Celecoxib Related Compound B; N-De(4-sulfonamidophenyl)-N'-(4-sulfonamidophenyl) Celecoxib; Celecoxib Isomeric Impurity





![N-ETHYL AZILSARTAN MEDOXOMIL (25 mg) ((5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2′-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylate)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)